CA2353804A1 - Regulation de la croissance myogene par modulation de l'activite wnt - Google Patents

Regulation de la croissance myogene par modulation de l'activite wnt Download PDF

Info

Publication number
CA2353804A1
CA2353804A1 CA 2353804 CA2353804A CA2353804A1 CA 2353804 A1 CA2353804 A1 CA 2353804A1 CA 2353804 CA2353804 CA 2353804 CA 2353804 A CA2353804 A CA 2353804A CA 2353804 A1 CA2353804 A1 CA 2353804A1
Authority
CA
Canada
Prior art keywords
cells
wnt
cell
muscle
myogenesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2353804
Other languages
English (en)
Inventor
Ilona Skerjanc
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
University of Western Ontario
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Western Ontario filed Critical University of Western Ontario
Priority to CA 2353804 priority Critical patent/CA2353804A1/fr
Publication of CA2353804A1 publication Critical patent/CA2353804A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA 2353804 2001-07-26 2001-07-26 Regulation de la croissance myogene par modulation de l'activite wnt Abandoned CA2353804A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2353804 CA2353804A1 (fr) 2001-07-26 2001-07-26 Regulation de la croissance myogene par modulation de l'activite wnt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2353804 CA2353804A1 (fr) 2001-07-26 2001-07-26 Regulation de la croissance myogene par modulation de l'activite wnt

Publications (1)

Publication Number Publication Date
CA2353804A1 true CA2353804A1 (fr) 2003-01-26

Family

ID=4169559

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2353804 Abandoned CA2353804A1 (fr) 2001-07-26 2001-07-26 Regulation de la croissance myogene par modulation de l'activite wnt

Country Status (1)

Country Link
CA (1) CA2353804A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004113513A2 (fr) 2003-06-25 2004-12-29 Ottawa Health Research Institute Procedes et compositions pour moduler la croissance et la differentiation des cellules souches
WO2005118782A2 (fr) * 2004-04-16 2005-12-15 Hydra Biosciences, Inc. Methodes favorisant la proliferation des cellules cardiaques
EP2226080A1 (fr) * 2009-03-05 2010-09-08 Universiteit Maastricht Peptides antagonistes pour frizzled-1 et frizzled-2

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004113513A2 (fr) 2003-06-25 2004-12-29 Ottawa Health Research Institute Procedes et compositions pour moduler la croissance et la differentiation des cellules souches
US7541183B2 (en) 2003-06-25 2009-06-02 Ottawa Health Research Institute Growth and differentiation of adult muscle stem cells with activators or inhibitors of Wnt signaling
AU2004249812B2 (en) * 2003-06-25 2011-06-30 Ottawa Hospital Research Institute Methods and compositions for modulating stem cell growth and differentiation
AU2004249812B8 (en) * 2003-06-25 2011-09-15 Ottawa Hospital Research Institute Methods and compositions for modulating stem cell growth and differentiation
WO2005118782A2 (fr) * 2004-04-16 2005-12-15 Hydra Biosciences, Inc. Methodes favorisant la proliferation des cellules cardiaques
WO2005118782A3 (fr) * 2004-04-16 2006-06-29 Hydra Biosciences Inc Methodes favorisant la proliferation des cellules cardiaques
EP2226080A1 (fr) * 2009-03-05 2010-09-08 Universiteit Maastricht Peptides antagonistes pour frizzled-1 et frizzled-2
WO2010100035A1 (fr) * 2009-03-05 2010-09-10 Universiteit Maastricht Peptides antagonistes de frizzled-1 et frizzled-2
US20120014876A1 (en) * 2009-03-05 2012-01-19 Academisch Ziekenhuis Maastricht Antagonistic peptides for frizzled-1 and frizzled-2
US8598122B2 (en) 2009-03-05 2013-12-03 Universiteit Maastricht Antagonistic peptides for frizzled-1 and frizzled-2

Similar Documents

Publication Publication Date Title
Flanders et al. Smad‐3 as a mediator of the fibrotic response
RU2304585C2 (ru) Очищенный иммуногенный белок, его фрагменты и производные
JP5603040B2 (ja) Ｔｗｅａｋ関連状態を治療するための方法
US20060035849A1 (en) Methods and composition for modulating type I muscle formation using pgc-1 alpha
JP2000506732A (ja) 細胞外マトリックスシグナリング分子
PT1140969E (pt) Fragmentos do factor de crescimento de tecido conectivo e os seus métodos e utilizações
JP2001037493A (ja) 新規成長因子およびそれをコードする遺伝子配列
CA2353804A1 (fr) Regulation de la croissance myogene par modulation de l'activite wnt
WO2002094842A2 (fr) Regulation de la myogenese par modulation de l'activite de la proteine-kinase p38 associee aux membranes
US20040091468A1 (en) Novel transcriptional mediators of blood vessel development and endothelial differentiation
US20030211141A1 (en) Genetic and protein manipulation of betaIG-H3 for the treatment and cure of muscular dystrophies
Flood et al. The role of glutamate signalling in rheumatoid arthritis
Talbot et al. Fluorescence lifetime imaging of articular cartilage
Blain et al. Changes in tendon extracellular matrix composition with age
Zhou et al. Factors affecting oxygen concentration gradients across articular cartilage
Blain et al. The role of the cytoskeleton in articular cartilage chondrocyte homeostasis
Jones et al. PRG‐4/SZP N‐and C‐terminal domains: cloning, expression and characterization
Garrigue‐Antar et al. Role of the EGF‐like domains in mammalian tolloid (mTLD) secretion and procollagen C‐proteinase activity
Yu et al. The importance of elastin and fibulin‐5 on spine development: a study of elastin KO and fibulin‐5 KO on the development of vertebral body and intervertebral disc
Wicks et al. Novel mechanisms for regulating the TGF‐β‐/Smad‐signalling pathway
Young et al. The role of acetylation in Timp‐1 regulation
Derham et al. Identification of cell markers of the nucleus and annulus of bovine intervertebral discs
Curtis et al. Gene expression and matrix proteinase activity in osteochondrosis dessicans
Yung et al. Emodin ameliorates glucose‐induced fibronectin synthesis in human peritoneal mesothelial cells by inhibiting PKC‐α activation
Richardson et al. Proteomics of tendon ECM assembly

Legal Events

Date Code Title Description
FZDE Dead